Chemical Structure (Tazarotene 01)
Tazarotene Aerosol, Foam
Product Images NDC 68308-685
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tazarotene (NDC 68308-685). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure A (Tazarotene 02)
Figure B (Tazarotene 03)
Figure C (Tazarotene 04)
Figure D (Tazarotene 05)
Figure E (Tazarotene 06)
Principal Display Panel (50 g Can Carton)
This is a description of a medication called Tazarotene Foam. It contains 1mg/g tazarotene, as well as other ingredients such as ascorbic acid and butylated hydroxytoluene. The medication is intended for topical use only and comes in a pressurized canister. The canister should be shaken before use and held upright while dispensing. The medication should be used only as prescribed by a physician and should be kept out of reach of children. The canister should not be punctured or exposed to heat, and should be stored at a temperature between 20°C to 25°C (68°F to 77°F). The manufacturer is Mayne Pharma, and the product is distributed in Canada. There is contact information provided for suspected adverse reactions.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
